Candida parapsilosis, which was previously considered to be a complex of three genetically distinct groups, has emerged as a significant agent of nosocomial infections. Recently, this complex was separated into three species: C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis. In Tunisia, data pertaining to these fungi are limited. Thus, the purpose of our study was to determine by BanI PCR-RFLP and ITS sequencing, the occurrence of Candida parapsilosis complex among 182 isolates identified as C. parapsilosis by phenotypical methods. C. parapsilosis sensu stricto represented 94.5% of all isolates, while C. metapsilosis and. C. orthopsilosis were identified in 3.3% and 2.2%, respectively. Sequence analysis of internal transcribed spacer region confirmed and revealed only one genotype among the C. parapsilosis sensu stricto strains, three genotypes among six C. metapsilosis strains and two genotypes among four C. orthopsilosis strains.
Introduction
Among non-albicans Candida species, C. parapsilosis currently stands out as the second or third most common yeast species isolated from blood cultures in Latin American, Canada, Europe, and Asia. [1] [2] [3] In Tunisia, although no national survey data are available, several single-center studies reported the increasing prevalence of C. parapsilosis. 4 In Sfax, it was the fourth most frequent yeast species isolated from patients with candidemia. 5 Candida parapsilosis has been considered a clonal organism in the past. Prior to 2005, it was separated into three groups, I to III. However, further genetic studies revealed sufficient differences that have led to the separation of the groups into closely related, distinct species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. 6 C. parapsilosis complex species exhibit differences in geographical distribution, in vitro susceptibilities to antifungal agents, the nature of their virulence and biofilm formation. [7] [8] [9] This difference in antifungal susceptibility among the three species has led to an increased interest in the study of C. parapsilosis complex species. C. parapsilosis is responsible for the vast majority of clinical disease, and few medical microbiology laboratories distinguish between these species, especially since commercial systems are not sufficient to differentiate between them. Because of the medical importance of C. parapsilosis in our area, we examined the genetic variability of isolates from different clinical specimens using PCR RFLP of SADH gene and PCR sequencing of ITS region.
Materials and methods

C. parapsilosis isolates
A total number of 182 C. parapsilosis isolates analysed in this study were recovered from clinical samples received by Department of Parasitology-Mycology, University Hospital, Sfax, Tunisia, during a 14-year period (from January 2002 to January 2016). The isolates obtained from various clinical specimens including blood (35.2%), urine (17%), auricular samples (24.2%) respiratory tract (2.2%), catheters (4.9%), and other sites such as skin (4.4%), nails (1.1%), oral cavity (1.1%), vagina (0.5%), peritoneal fluid (0.5%), and hand carriage (8.8%).
Four reference strains were included: C. parapsilosis (ATCC 22019), C. orthopsilosis (1219482, 1343124) and C. metapsilosis (1240011).
Conventional identification
Conventional identification was based on the macroscopic appearance of colonies on the chromogenic agar media and on the assimilation of organic substrates (API ID32C; BioMérieux, Marcy l'Etoile, France) in accord with the directions of the manufacturer.
DNA extraction
The genomic DNA was extracted using a QIAamp DNA Mini Kit (QIAGEN) as indicated by the manufacturer's instruction, and eluted with 50 μl of sterile water.
PCR and RFLP
Amplification of SADH gene was performed with primers S1F (5 -GTTGATGCTGTTGGATTGT-3 ) and S1R (5 -CAATGCCAAATCTCCCAA-3 ) as designated by Tavanti et al. 6 Amplification reactions were performed in final volumes of 50 μl containing 400 ng of genomic DNA, 10 μl of 5× reaction buffer (pH 8.5), 25 mM MgCl2, 0.2 mM (each) dATP, dCTP, dGTP, and dTTP (Promega), 20 pmol of each primer and 2.5 U of GOTaq R DNA polymerase (Promega).
PCR was performed in a thermocycler (Eppendorf), it consisted of an initial denaturation at: Amplification of the ITS1, 5.8S and ITS2 regions was performed using primers ITS1 (5 -TCCGTAGGTGAACCTGCGG-3 ) and ITS4 (5 -TCCTCCGCTTATTGATA-3 ) as described by White et al. 10 PCR products were purified using PCR Clean-up system (Promega). Both strands of the PCR products were directly sequenced with a DNA Sequencing Kit BigDye R Terminator v3.1 cycle Sequencing Kits (Applied Biosystems) with primer ITS1-ITS4 and an automatic sequencer (ABI 3730 × 1 DNA Analyser), according to the manufacturer's instructions. The sequences generated were used in BLAST searches (http://www.ncbi.nlm.nih.gov) to confirm the preliminary identification.
Phylogenetic analysis
The above mentioned sequences were aligned using the ClustalX V2.1 program 11 as implemented in BioEdit 12 , sequence alignment Editor Version. 7.0.9.0 Software. Phylogenetic tree of ITS rDNA was obtained using MEGA (Molecular Evolutionary Genetic analysis program) version 6. 13 Tree was created using UPGMA method. For bootstrap analysis, 1000 replicates were chosen for UPGMA tree. The evolutionary distance between organisms was indicated by the horizontal branch length, which reflects the number of nucleotide substitutions per site along that branch from the node to the endpoint. In the UPGMA tree, the percentage of bootstrap samplings that support the interior branches was noted. 
Statistical analysis
All statistical analyses were performed using IBM SPSS software (version 20.0; IBM SPSS Inc., New York, USA). Categorical variables were compared using Pearson's χ 2 test.
A P value of .05 was considered significant.
Results
Patient characteristics
The general characteristics of the patients with candidemia are shown in table 1. Fever was the most frequent clinical manifestation (84.3%), and 11.8% patients presented septic shock.
PCR and RFLP
PCR amplifications of the SADH gene fragment revealed a band with a size of 717 bp for C. parapsilosis strains. According to the BanI restriction pattern, our isolates were molecularly discriminated as follow: C. parapsilosis sensu stricto has one BanI restriction site (521, 196 bp), C. metapsilosis has three restriction sites (375, 189, 93, and 60 bp), and C. orthopsilosis has no restriction site. Of the 182 isolates presumed to be C. parapsilosis, 94.5% were C. parapsilosis sensu stricto, 3.3% were C. metapsilosis and 2.2% were C. orthopsilosis. C. parapsilosis sensu stricto was recovered from all types of biological samples, particularly associated with blood. C. metapsilosis was isolated from blood, urine, skin and auricular samples. Two strains were isolated from blood and skin of the same patient. Four strains of C. orthopsilosis were isolated from blood, urine, auricular sample, and hand carriage. No statistical significant correlation was observed between the genospecies and infection sites (P = .608).
PCR-Sequencing
By comparative sequence analysis of the ITS region, all the 52 isolates studied were unequivocally identified to the species level, with a sequence similarity ≥99%, which was in concordance with PCR-RFLP.
Among the 42 C. parapsilosis sensu stricto sequenced strains, only one ITS sequence type (520 bp) was found. This sequence has been deposited in the Genbank database under the accession number KT948326.
For the six strains of C. metapsilosis, three ITS sequence types (530, 531, and 532 bp) were found and deposited in the Genbank database under the accession number: KU665248 (530 bp), KU665249 (530 bp), KU665250 (531 bp), KU665251 (531 bp), KX421284 (531 bp) and KU665252 (532 bp).
For the four strains of C. orthopsilosis, two ITS sequence types (511 for three strains and 512 bp for one strain) were found and deposited in the Genbank database under the accession number: KU665253, KU665254, KU665255, and KU665256.
No statistical significant correlation was observed between ITS sequence type and infection sites for C. metapsilosis and C. orthopsilosis (P = .525). For patients with candidemia, no statistical significant association was observed between the underlying disease and ITS sequence type (P = .421).
The alignment of these different sequence types of C. parapsilosis complex is shown in figure 1 .
Phylogenetic analysis based on the ITS sequences separated the C. parapsilosis complex strains into three clusters (figure 2).
Discussion
C. parapsilosis is responsible for a broad variety of clinical manifestations and is of considerable importance due its propensity to easily colonize hospital environments, including medical devices, and health care workers. 14 Since their identification, species belonging to the C. parapsilosis complex have been differentiated through the use of molecular methods due to the fact that they are indistinguishable when conventional biochemical tests are used. 15 Since 2005, when C. parapsilosis was recognized as a complex composed by C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis, 6 surveillance data about the distribution, antifungal resistance, and virulence factors of these three species are continually collected and analyzed by a number of authors. [16] [17] [18] In Tunisia, limited epidemiological data pertaining to the C. parapsilosis complex is available. Observational studies in Tunisia primarily relied on conventional carbon-assimilation methods for identification and no discrimination of the three related species had ever been conducted. Previously, C. parapsilosis has been found to be the fourth most frequent Candida species responsible for bloodstream infection in Sfax. 5 Although all isolates of C. parapsilosis studied in our work have been identified by phenotypic methods, these methods were not able to differentiate among the C. parapsilosis complex species, which are phenotypically identical. Moreover, there are several other techniques that can be used for strain typing and identification of C. parapsilosis species complex 19 such as amplified fragment length polymorphism (AFLP), 20 protein fingerprinting analysis by MALDI-TOF technology, 21 DNA microarray 22 and pyrosequencing of specific signature sequences of the ribosomal DNA. 23 Amplification of the SADH gene followed by BanI restriction enzyme digestion has been used as a rapid and reliable method with high discriminative power for C. parapsilosis complex species. 24 RFLP offers the advantage of simultaneously identifying and genotyping C. orthopsilosis, C. metapsilosis, and C. parapsilosis isolates and represents a reproducible tool for genetic analysis. 6, 24 This method has become a standard method that has been widely applied in subsequent studies. However, Mirhendi et al. revealed that the SADH PCR RFLP with the enzyme BanI successfully separated C. parapsilosis sensu stricto from the two new species, but misclassification of C. orthopsilosis and C. metapsilosis must be expected in a routine setting. So, they proposed a new SADH PCR-RFLP with NlaIII for the discrimination of representatives of the C. parapsilosis complex. 25 In our study, ITS sequencing was used as the "gold standard" for identification to the species level of clinical strains tested. Therefore, the possibility of misidentification due to a possible point mutation in C. parapsilosis sensu stricto was excluded. 26 Asadzadeh et al. successfully designed four pairs of primers which specifically targeted the ITS regions of each species and the entire complex as well. 27 ITS sequencing was proven to be sufficient for the correct identification of C. parapsilosis complex, but it is quite time consuming and not always appropriate in clinical laboratories for urgent cases. Thus, species-specific amplification of the ITS region and PCR-RFLP analyses of the SADH gene were concordant for all clinical isolates in Sfax and identified 94.5% of isolates as C. parapsilosis sensu stricto, while 3.3% and 2.2% corresponded to C. metapsilosis and C. orthopsilosis, respectively.
The distribution of the three species of C. parapsilosis complex varies in different geographical regions. In North America and Europe, the incidence of candidemia due to C. metapsilosis has been reported to range from 1.1% to 6.9% and that of C. orthopsilosis from 3.6% to 9%. Of the 1929 C. parapsilosis invasive clinical isolates from the ARTEMIS antifungal surveillance program, 6.1% were identified as C. orthopsilosis and 1.8% as C. metapsilosis. 8 This study confirmed that C. parapsilosis sensu stricto is predominant among isolates from blood and other clinical samples. The higher prevalence of C. parapsilosis sensu stricto may be related to its ubiquitous nature, since it is commonly isolated from different environmental sources and may be related to the expression of more factors of virulence. 26 The percentage of C. orthopsilosis varies greatly by region, with the highest percentage from South America (37%) and the lowest from Africa (0.7%). 8, 28 The distributions in Asia and Europe varied from 0% to 24.4% and 0% to 23.5%, respectively. 3, [29] [30] [31] In this study, it represented 2.2%. One of the four strains was particularly associated with carriage by the hands of health-care workers in ICU-neonatal department. This suggests a possible pathway of transmission in cases of C. orthopsilosis bloodstream infections in neonates diagnosed by another study. 32 Interestingly, C. orthopsilosis isolates were obtained from other biological samples than blood, like urine, respiratory tract samples, ascite fluid, abscesses, and mucosal surfaces. 8, 26 C. metapsilosis is rarely isolated from clinical samples. 16, 33 Europe is generally considered to be the region with the highest rate of C. metapsilosis. 8, 30 In our study, C. metapsilosis was the second most frequently species of the cryptic complex followed by C. orthopsilosis. Although some studies found that C. metapsilosis does not cause bloodstream infections, 32 it was isolated from blood culture and the skin from one of our patients with candidemia. So, we suggest that skin colonization was the source of blood infection. Moreover, a high prevalence of C. metapsilosis has been recently reported from Chinese skin samples. 3 Generally, C. metapsilosis is more often isolated from local infections. 8, 26 Additionally, the species is less virulent in tissue culture models of infection than C. parapsilosis or C. orthopsilosis. 9 Other data suggest that C. metapsilosis is an environmental organism, whereas C. parapsilosis and C. orthopsilosis evolved by adaptation to mammalian niches. 6, 34 Comparative sequence analysis showed that the diversity in the IGS1 region was higher than in the ITS sequences. Although differences in the ITS region are great enough to discriminate among species of C. parapsilosis complex they are based on a few nucleotides. 6 According to Gago et al., phylogenetic analysis of the ITS region using the maximum likelihood method was also not effective in differentiating between C. orthopsilosis and C. metapsilosis. 35 However,
we have demonstrated in our study that C. orthopsilosis and C. metapsilosis belonged to two different clusters if phylogenetic analysis of the ITS region used the UPGMA method. In this study, only one ITS sequence type was found for 42 C. parapsilosis sensu stricto strains. This finding is very interesting considering that C. parapsilosis is described as a prevalently clonal species with limited DNA sequence variability in conserved genes, even with isolates collected from distant geographical regions. 20, 36 The low level of variability suggests a clonal or selfing strategy of reproduction, supporting the hypothesis of a successful species recently emerged as a genetically homogeneous population diverged from a common ancestor. 36 Interestingly, although C. parapsilosis isolates essentially lack DNA sequence variability, the relatively high level of genetic heterogeneity among C. orthopsilosis isolates suggests that C. parapsilosis might have evolved from this species. 6 This last hypothesis is supported by this study (two ITS sequence types for four strains) and by others who have described C. orthopsilosis as the most heterogeneous of the psilosis species, 14,27 which could be related to sexual and parasexual reproduction. 35, 37, 38 Moreover, high sequence dissimilarities were found among our isolates of C. metapsilosis consistently with what was observed by Gomez-Lopez A et al. 16 The greater genetic variability of these newly described yeasts compared with C. parapsilosis sensu stricto has caused difficulties in the development of molecular techniques for the subtyping of these yeasts. 6, 29 Because of the small numbers of the newly described isolates, no statistical significant association was observed between ITS sequence type and infection sites, and between the underlying disease and ITS sequence type.
In conclusion, this study presented the identification of the two newly described Candida species that are closely related to C. parapsilosisis from different clinical sites of our patients. Accurate species identification among the C. parapsilosis complex is also becoming crucial in clinical management. The rapid detection of C. parapsilosisis is now clinically relevant because the revised recommendations for the treatment of candidiasis favor fluconazole in comparison with echinocandins as first-line therapy for infections due to this species. Moreover, C. orthopsilosis and C. metapsilosis appear to be more susceptible to echinocandins and less susceptible to fluconazole than C. parapsilosis sensu stricto. 8, 16, 33 Further investigations of the mode of transmission, virulence, and antifungal susceptibilities of these newly described species are thus essential in our region.
